Rapid Micro Biosystems Inc. has announced its financial results for the second quarter of 2025. The company reported a total revenue of $7.3 million, marking a 10% growth compared to the second quarter of 2024. The recurring revenue for the quarter increased by 15% from the previous year. The gross margin improved by seven percentage points to 4%. The company's product revenue grew by 6%, driven by mid-teens growth in consumables, while service revenue saw an 18% increase. Rapid Micro Biosystems reaffirmed its full-year 2025 total revenue guidance of at least $32 million. Additionally, the company entered into a five-year, $45 million term loan facility with Trinity Capital Inc., receiving $20 million at close. This facility aims to bolster the company's financial position and support its strategic priorities for long-term growth and shareholder value.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapid Micro Biosystems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001380106-25-000169), on August 12, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.